Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 30, 2019Clinical Cancer ResearchOpen Access

Clinical Utility of Plasma Cell-Free DNA in Adult Patients with Newly Diagnosed Glioblastoma: A Pilot Prospective Study

View Full Paper
Ask AI
Bookmark
Share

Authors

SBStephen BagleyUniversity of PennsylvaniaSNSeyed Ali NabavizadehShiraz University of Medical SciencesJMJazmine J. MaysHarvard University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bagley et al. (2019) studied this question.

synapsesocial.com/papers/69df47c5d5404a0bea592cbchttps://doi.org/10.1158/1078-0432.ccr-19-2533
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Analysis of cell-free circulating tumor DNA in 419 patients with glioblastoma and other primary brain tumors2019 · 175 citations
  2. 2Cell-free DNA (cfDNA): Clinical Significance and Utility in Cancer Shaped By Emerging Technologies2016 · 363 citations
  3. 3Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non–Small Cell Lung Cancer2018 · 502 citations
  4. 4Orthogonal Comparison of Four Plasma NGS Tests With Tumor Suggests Technical Factors are a Major Source of Assay Discordance2019 · 186 citations
  5. 5Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer2018 · 142 citations